Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes

Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study

(2014) Agnieszka Kaplon-Cieslicka et al.   Cardiovascular Diabetology

Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity

(2014) Anno Saris et al.   THROMBOSIS AND HAEMOSTASIS

Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking

(2014) B. Łabuz-Roszak et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH

(2013) M. Cattaneo et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease

(2012) Jean-Guillaume Dillinger et al.   AMERICAN HEART JOURNAL

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes

(2012) Giorgia De Berardis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus

(2012) B. A. LEMKES et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes

(2012) B. ROCCA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Guidelines for the laboratory investigation of heritable disorders of platelet function

(2011) Paul Harrison et al.   BRITISH JOURNAL OF HAEMATOLOGY

Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease

(2011) Davide Capodanno et al.   Circulation-Cardiovascular Interventions

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications

(2011) Galia Spectre et al.   THROMBOSIS AND HAEMOSTASIS

Review article: Coagulation and fibrinolysis in diabetes

(2010) SH Alzahrani et al.   Diabetes & Vascular Disease Research

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?

(2009) Hermione C Price et al.   Nature Reviews Cardiology

Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents

(2008) Arun Natarajan et al.   Diabetes & Vascular Disease Research